OPTIQUEL Trademark

Trademark Overview

On Thursday, December 9, 2021, a trademark application was filed for OPTIQUEL with the United States Patent and Trademark Office. The USPTO has given the OPTIQUEL trademark a serial number of 97163675. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, April 12, 2024. This trademark is owned by Enzo Biochem, Inc.. The OPTIQUEL trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic preparation for the treatment of ocular inflammation
optiquel

General Information

Serial Number97163675
Word MarkOPTIQUEL
Filing DateThursday, December 9, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, April 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2023

Trademark Statements

Goods and ServicesOphthalmic preparation for the treatment of ocular inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 15, 2021
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History

Party NameEnzo Biochem, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFarmingdale, US 11735
Party NameEnzo Biochem, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFarmingdale, US 11735

Trademark Events

Event DateEvent Description
Wednesday, September 21, 2022NON-FINAL ACTION E-MAILED
Monday, December 13, 2021NEW APPLICATION ENTERED
Wednesday, December 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, September 18, 2022ASSIGNED TO EXAMINER
Wednesday, September 21, 2022NON-FINAL ACTION WRITTEN
Wednesday, September 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 20, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2023SOU EXTENSION 1 FILED
Thursday, November 16, 2023SOU EXTENSION 1 GRANTED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 12, 2024SOU EXTENSION 2 FILED
Friday, April 12, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 12, 2024SOU EXTENSION 2 GRANTED
Saturday, April 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

optiquel inflammation ocular treatment preparation ophthalmic